A human commensal bacteria have been engineered to secrete GLP 1 (1-37), able to reprogram human and rat intestinal epithelial cells to glucose responsive insulin secreting cells expressing the β cells markers such as MafA, PDX 1 and forkhead box protein A2, in order to treat diabetes.2,5. The gene discussed is INS; the disease is diabetes mellitus.